PMC:7346000 / 1468-1668 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"32","span":{"begin":40,"end":45},"obj":"Chemical"}],"attributes":[{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:D001393"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"otericin B, as well as the emergence of azole-resistance. This clinical reality creates an urgency for new antifungal drugs currently in advanced clinical development with more promising pharmacokinet"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":9,"end":10},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"otericin B, as well as the emergence of azole-resistance. This clinical reality creates an urgency for new antifungal drugs currently in advanced clinical development with more promising pharmacokinet"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":40,"end":45},"obj":"Chemical"},{"id":"T8","span":{"begin":107,"end":123},"obj":"Chemical"},{"id":"T10","span":{"begin":118,"end":123},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_68452"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_35718"},{"id":"A9","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_86327"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"otericin B, as well as the emergence of azole-resistance. This clinical reality creates an urgency for new antifungal drugs currently in advanced clinical development with more promising pharmacokinet"}